← Back to Search

Early Follicular Phase (EFP) for Women's Health

N/A
Waitlist Available
Research Sponsored by Southern Illinois University Edwardsville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 5 weeks
Awards & highlights

Study Summary

This trial will analyze how different phases of the menstrual cycle affect a woman's response to resistance training.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 5 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in estrogen concentrations
Change in progesterone concentrations
Secondary outcome measures
Cardiorespiratory Fitness
Changes in diet
Fat mass (kg)
+5 more

Side effects data

From 2010 Phase 2 trial • 167 Patients • NCT00112151
66%
Other noncardiovascular serious adverse events
13%
Other nonserious adverse events
11%
Persistently elevated PSA
4%
Total serious cardiovascular adverse events
4%
Persistently elevated HCT >= 54%
2%
Elevated AUA
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Lower-range T
Higher-range T

Trial Design

4Treatment groups
Experimental Treatment
Group I: Late Luteal Phase (LLP)Experimental Treatment1 Intervention
Group II: Late Follicular Phase (LFP)Experimental Treatment1 Intervention
Group III: Early Luteal Phase (ELP)Experimental Treatment1 Intervention
Group IV: Early Follicular Phase (EFP)Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resistance Training
2019
Completed Phase 2
~1190

Find a Location

Who is running the clinical trial?

Southern Illinois University EdwardsvilleLead Sponsor
5 Previous Clinical Trials
52 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025